Home The Word Brain My Amedeo FAQ Privacy About   

2049 Chinese

The 20K Word Road to Mandarin Proficiency

By B. S. Kamps et al.

  Hypersensitivity Reaction

  Free Subscription


10 Allergy
1 Am J Respir Crit Care Med
3 Br J Dermatol
3 Contact Dermatitis
1 Int Arch Allergy Immunol
1 J Allergy Clin Immunol
10 J Asthma
3 J Dermatol
2 J Immunol
1 Pediatr Dermatol

  Retrieve available abstracts of this week’s articles:
HTML format
Single Articles


  1. SALAMEH P, Gutsche A, Aulenbacher F, Buttgereit T, et al
    Urticaria Control Test real-world performance: A post-hoc analysis.
    Allergy. 2024;79:229-232.

  2. WELLER K, Gimenez-Arnau AM, Baron J, Brehler R, et al
    Efficacy and safety of on-demand versus daily rupatadine in chronic spontaneous urticaria: A randomized trial.
    Allergy. 2024;79:93-103.
    PubMed         Abstract available

  3. METZ M, Kolkhir P, Altrichter S, Siebenhaar F, et al
    Mast cell silencing: A novel therapeutic approach for urticaria and other mast cell-mediated diseases.
    Allergy. 2024;79:37-51.
    PubMed         Abstract available

  4. MAGERL M, Schiffhorst G, Fanter L, Muller G, et al
    Patient-level indirect treatment comparison of lanadelumab versus pdC1-INH i.v. in hereditary angioedema patients: PATCH study.
    Allergy. 2024;79:215-224.
    PubMed         Abstract available

  5. DE MARCHI S, Cecchin E, De Marchi SU, Sechi LA, et al
    Impact of atopic respiratory disease on contact dermatitis.
    Allergy. 2024;79:242-245.

  6. GUTSCHE A, Salameh P, Aulenbacher F, Buttgereit T, et al
    Response to "Clinical applicability of the Urticaria control test in patients with chronic urticaria: Further evidence from 622 adult and pediatric patients with different disease subtypes".
    Allergy. 2024;79:265-267.

  7. ZHANG DG, Sorensen JA, Ghazanfar MN, Thomsen SF, et al
    Clinical applicability of the urticaria control test in patients with chronic urticaria: Further evidence from 622 adult and pediatric patients with different disease subtypes.
    Allergy. 2024;79:263-264.

  8. Correction to: Nomenclature of allergic diseases and hypersensitivity reactions: Adapted to modern needs: An EAACI position paper.
    Allergy. 2024;79:269-273.

  9. XU Y, Qiu Z, Gu C, Yu S, et al
    Propionate alleviates itch in murine models of atopic dermatitis by modulating sensory TRP channels of dorsal root ganglion.
    Allergy. 2024 Jan 2. doi: 10.1111/all.15998.
    PubMed         Abstract available

  10. VOSKAMP AL, de Jong NW, Jochems SP, Ozir-Fazalalikhan A, et al
    Early expansion of allergen-responsive LAP(+) B regulatory cells in allergic rhinitis but not in allergic asthma subjects during allergen immunotherapy.
    Allergy. 2024 Jan 3. doi: 10.1111/all.15973.

    Am J Respir Crit Care Med

  11. MOCHIZUKA Y, Enomoto N, Daisuke A, Inoue Y, et al
    "Bull's-eye" Sign and Its Longitudinal Change on High-Resolution Computed Tomography in Pulmonary Sarcoidosis.
    Am J Respir Crit Care Med. 2024;209:e1-e3.

    Br J Dermatol

  12. FUNCH AB, Glindvad Ahlstrom M, Johansen JD, Geisler C, et al
    Neutrophil Infiltration in Allergic Contact Dermatitis to Nickel.
    Br J Dermatol. 2024 Jan 4:ljad499. doi: 10.1093.

  13. YOO LJH, Stefanovic N, Watchorn RE
    Atopic Dermatitis and Autism: Tactile Hypersensitivity Impeding on Topical Therapy Use.
    Br J Dermatol. 2024 Jan 4:ljae005. doi: 10.1093.

  14. SMITH KA, Hiyoshi A, Vingeliene S, von Kobyletzki L, et al
    Atopic dermatitis and cognitive function: a sibling comparison study among males in Sweden.
    Br J Dermatol. 2024 Jan 3:ljae004. doi: 10.1093.

    Contact Dermatitis

  15. ZHANG Y, Hales MK, Lipman RE, Quan VL, et al
    Allergic contact dermatitis masquerading as retiform purpura.
    Contact Dermatitis. 2024 Jan 4. doi: 10.1111/cod.14497.

  16. GKOUSIAKI M, Karalis VD, Kyritsi A, Almpani C, et al
    Contact allergy caused by acrylates in nail cosmetics: A pilot study from Greece.
    Contact Dermatitis. 2024 Jan 2. doi: 10.1111/cod.14485.
    PubMed         Abstract available

  17. CAI SCS, Chong TYR, Goon AT, Leow YH, et al
    Taking aim at the wood: Allergic contact dermatitis in a rifle shooting athlete.
    Contact Dermatitis. 2024 Jan 1. doi: 10.1111/cod.14495.

    Int Arch Allergy Immunol

  18. LIN L, Dai F, Wei J, Chen Z, et al
    Biological Roles of 5-Oxo-6,8,11,14-Eicosatetraenoic Acid and the OXE Receptor in Allergic Diseases: Collegium Internationale Allergologicum Update 2024.
    Int Arch Allergy Immunol. 2024 Jan 4:1-10. doi: 10.1159/000535560.
    PubMed         Abstract available

    J Allergy Clin Immunol

  19. SILVERBERG JI, Strober B, Feinstein B, Xu J, et al
    Efficacy and safety of rademikibart (CBP-201), a next-generation monoclonal antibody targeting IL-4Ralpha, in adults with moderate-to-severe atopic dermatitis: a phase 2 randomized trial (CBP-201-WW001).
    J Allergy Clin Immunol. 2023 Dec 27:S0091-6749(23)02546.
    PubMed         Abstract available

    J Asthma

  20. PUZZI VC, Mara de Oliveira J, Alves TB, Silva JPDC, et al
    Reliability and validity of the London Chest Activity of Daily Living scale for adults with asthma.
    J Asthma. 2023 Jul 7:1-25. doi: 10.1080/02770903.2023.2234990.
    PubMed         Abstract available

  21. SUN Y, Na R, Zhu L, Yang X, et al
    Establishment of a homogeneous chemiluminescence immunoassay for cat dander sIgE antibody detection.
    J Asthma. 2024;61:10-19.
    PubMed         Abstract available

  22. PACACI CETIN G, Arslan B, Yilmaz I
    Doxycycline may be more clinically effective in Type 2 chronic rhinosinusitis nasal polyp comorbid with asthma.
    J Asthma. 2023 Jul 12:1-9. doi: 10.1080/02770903.2023.2236696.
    PubMed         Abstract available

  23. LICCARDI G, Martini M, Bilo MB, Milanese M, et al
    Poorly controlled asthma and psychological health in African American young adults: Why is phenotyping necessary? Suggestions from a multidisciplinary "Stress-Asthma Working Group".
    J Asthma. 2023 Jul 13:1-6. doi: 10.1080/02770903.2023.2236704.

  24. PRIETO-GARCIA A, Peligros MI, Perez Tamayo I, Zubeldia JM, et al
    Long-term use of mepolizumab in a case of chronic eosinophilic pneumonia: extending interval dosing.
    J Asthma. 2024;61:69-71.
    PubMed         Abstract available

  25. DOMINGUEZ-ORTEGA J, Laorden D, Vilchez-Sanchez F, Banas-Conejero D, et al
    Cost-effectiveness and resource use analysis of patients with asthma before and after treatment with mepolizumab in a real-life setting.
    J Asthma. 2023 Jul 28:1-19. doi: 10.1080/02770903.2023.2241905.
    PubMed         Abstract available

  26. SINGH H, Khurana A, Kumar A, Saluja R, et al
    Serum Levels of Interleukin-33, soluble ST2 and IgE in patients with Asthma: A case-control study.
    J Asthma. 2023 Aug 7:1-8. doi: 10.1080/02770903.2023.2244579.
    PubMed         Abstract available

  27. PERLATO M, Mecheri V, Vivarelli E, Accinno M, et al
    "Patient remodeling" as a consequence of uncontrolled and prolonged OCS use in severe asthma: how biologic therapy can reverse a dangerous trend.
    J Asthma. 2023 Aug 24:1-4. doi: 10.1080/02770903.2023.2241910.
    PubMed         Abstract available

  28. MARTINEZ MORAGON E, Entrenas Costa LM, Sanchez-Covisa Hernandez J, de Prado Moncusi A, et al
    A cross-sectional study to evaluate utility measure and health-related quality of life (HRQoL) among patients with severe uncontrolled asthma in Spain.
    J Asthma. 2023 Sep 1:1-12. doi: 10.1080/02770903.2023.2241891.
    PubMed         Abstract available

  29. HASHEM E, Kandil F, Alsharif F, Sharif L, et al
    Assessment of Lifestyle and Coping Strategies among Asthmatic Patients during the Covid-19 Crisis.
    J Asthma. 2023 Oct 23:1-18. doi: 10.1080/02770903.2023.2272790.
    PubMed         Abstract available

    J Dermatol

  30. SATOH TK, Neulinger MM, Stadler PC, Aoki R, et al
    Immune checkpoint inhibitor-induced epidermal necrolysis: A narrative review evaluating demographics, clinical features, and culprit medications.
    J Dermatol. 2024;51:3-11.
    PubMed         Abstract available

  31. CHEN L, Xu Q, Liu J, Li Z, et al
    Severe acute urticaria is associated with elevated plasma levels of D-dimer.
    J Dermatol. 2024;51:81-87.
    PubMed         Abstract available

  32. KATSUTA M, Nobeyama Y, Hirafuku K, Tashiro K, et al
    Characteristics of mild and severe apalutamide-related cutaneous adverse events in patients with prostate cancer: A review of the literature.
    J Dermatol. 2023 Sep 21. doi: 10.1111/1346-8138.16972.
    PubMed         Abstract available

    J Immunol

  33. CAMPBELL E, Hesser LA, Berni Canani R, Carucci L, et al
    A Lipopolysaccharide-Enriched Cow's Milk Allergy Microbiome Promotes a TLR4-Dependent Proinflammatory Intestinal Immune Response.
    J Immunol. 2024 Jan 3:ji2300518. doi: 10.4049/jimmunol.2300518.
    PubMed         Abstract available

  34. BELIKOFF BG, Vaickus LJ, Sitkovsky M, Remick DG, et al
    Corrections: A2B adenosine receptor expression by myeloid cells is pro-inflammatory in murine allergic-airway inflammation.
    J Immunol. 2024 Jan 3:ji2300855. doi: 10.4049/jimmunol.2300855.
    PubMed         Abstract available


  35. MOLLAH F, Zacharek MA, Benjamin MR
    What Is Alpha-Gal Syndrome?
    JAMA. 2024;331:86.

    Pediatr Dermatol

  36. REDDY P, Mahajan R, Mehta H, De D, et al
    Increased prevalence of metabolic syndrome and non-alcoholic fatty liver disease in children with atopic dermatitis: A case-control study from northern India.
    Pediatr Dermatol. 2024 Jan 2. doi: 10.1111/pde.15502.
    PubMed         Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Hypersensitivity Reaction is free of charge.